Brevan Howard Capital Management LP
Position in BSX — Boston Scientific Corp
CIK 1512857
ST. HELIER, Y9
Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,765,891
-$8,376,193 QoQ
Shares Held
171,568
-14.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Brevan Howard Capital Management LP holds $45,284,146 across 37 Medical Devices names. BSX ranks #1 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
This page
|
171,568 | $10,765,891 | |
| 2 | PODD |
Insulet Corp
|
21,574 | $4,527,088 | |
| 3 | DXCM |
Dexcom Inc
|
49,242 | $3,092,397 | |
| 4 | SYK |
Stryker Corp
|
8,157 | $2,680,308 | |
| 5 | EW |
Edwards Lifesciences Corp
|
33,116 | $2,651,928 | |
| 6 | ESTA |
Establishment Labs Holdings Inc.
|
43,726 | $2,482,762 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
16,787 | $1,981,201 | |
| 8 | MASI |
Masimo Corp
|
10,628 | $1,890,402 |
All Filings in BSX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,765,891 | 171,568 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,142,084 | 200,756 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,209,389 | 73,844 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,367,131 | 77,899 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,889,444 | 88,119 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,694,408 | 97,340 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,752,913 | 32,851 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,041,175 | 13,520 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||